{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:33:35Z","timestamp":1780616015002,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"research funds from the Division of Rheumatology at the University of Alabama at Birmingham","award":["No number"],"award-info":[{"award-number":["No number"]}]},{"name":"the resources and use of facilities at the Birmingham VA Medical Center, Birmingham, Alabama, USA","award":["No number"],"award-info":[{"award-number":["No number"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12877-018-0975-0","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:43:14Z","timestamp":1542199394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Gout and dementia in the elderly: a cohort study of Medicare claims"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"975_CR1","unstructured":"Dementia and Alzheimer\u2019s leading cause of death in England and Wales. https:\/\/www.theguardian.com\/society\/2016\/nov\/14\/dementia-and-alzheimers-leading-cause-of-death-england-and-wales . Accessed 10 Nov 2018."},{"issue":"2","key":"975_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31887\/DCNS.2009.11.2\/bdubois","volume":"11","author":"B Dubois","year":"2009","unstructured":"Dubois B, Picard G, Sarazin M. Early detection of Alzheimer\u2019s disease: new diagnostic criteria. Dialogues Clin Neurosci. 2009;11(2):135\u20139.","journal-title":"Dialogues Clin Neurosci"},{"issue":"9","key":"975_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922\u201335.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"975_CR4","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136\u20139.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"975_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1503\/cmaj.070798","volume":"178","author":"HH Feldman","year":"2008","unstructured":"Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H. Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ. 2008;178(7):825\u201336.","journal-title":"CMAJ"},{"issue":"3\u20134","key":"975_CR6","first-page":"189","volume":"5","author":"T Erkinjuntti","year":"1994","unstructured":"Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia. 1994;5(3\u20134):189\u201392.","journal-title":"Dementia"},{"issue":"8","key":"975_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734\u201346.","journal-title":"Lancet Neurol"},{"issue":"1","key":"975_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5498\/wjp.v1.i1.8","volume":"1","author":"C Humpel","year":"2011","unstructured":"Humpel C, Hochstrasser T. Cerebrospinal fluid and blood biomarkers in Alzheimer\u2019s disease. World J Psychiatry. 2011;1(1):8\u201318.","journal-title":"World J Psychiatry"},{"issue":"1","key":"975_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","volume":"29","author":"C Humpel","year":"2011","unstructured":"Humpel C. Identifying and validating biomarkers for Alzheimer\u2019s disease. Trends Biotechnol. 2011;29(1):26\u201332.","journal-title":"Trends Biotechnol"},{"issue":"10","key":"975_CR10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2105\/AJPH.88.10.1452","volume":"88","author":"H Aguero-Torres","year":"1998","unstructured":"Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, von Strauss E, Winblad B. Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health. 1998;88(10):1452\u20136.","journal-title":"Am J Public Health"},{"issue":"2","key":"975_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/jnnp.2005.072983","volume":"77","author":"S Banerjee","year":"2006","unstructured":"Banerjee S, Smith SC, Lamping DL, Harwood RH, Foley B, Smith P, Murray J, Prince M, Levin E, Mann A, et al. Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia. J Neurol Neurosurg Psychiatry. 2006;77(2):146\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"975_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-014-0192-4","volume":"12","author":"F Bunn","year":"2014","unstructured":"Bunn F, Burn AM, Goodman C, Rait G, Norton S, Robinson L, Schoeman J, Brayne C. Comorbidity and dementia: a scoping review of the literature. BMC Med. 2014;12:192.","journal-title":"BMC Med"},{"issue":"4","key":"975_CR13","first-page":"3","volume":"63","author":"NB Johnson","year":"2014","unstructured":"Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease C, Prevention. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. MMWR Suppl. 2014;63(4):3\u201327.","journal-title":"MMWR Suppl"},{"issue":"1","key":"975_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63\u201375 e62.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"975_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1212\/WNL.52.1.78","volume":"52","author":"LJ Launer","year":"1999","unstructured":"Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM incidence research group and work groups. European studies of dementia. Neurology. 1999;52(1):78\u201384.","journal-title":"Neurology"},{"issue":"1","key":"975_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000329097","volume":"34","author":"B Afsar","year":"2011","unstructured":"Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol. 2011;34(1):49\u201354.","journal-title":"Am J Nephrol"},{"issue":"1","key":"975_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11739-014-1098-z","volume":"10","author":"AF Cicero","year":"2015","unstructured":"Cicero AF, Desideri G, Grossi G, Urso R, Rosticci M, D'Addato S, Borghi C, Brisighella Heart Study G. Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella study. Intern Emerg Med. 2015;10(1):25\u201331.","journal-title":"Intern Emerg Med"},{"key":"975_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.exger.2016.04.017","volume":"81","author":"L Perna","year":"2016","unstructured":"Perna L, Mons U, Schottker B, Brenner H. Association of cognitive function and serum uric acid: are cardiovascular diseases a mediator among women? Exp Gerontol. 2016;81:37\u201341.","journal-title":"Exp Gerontol"},{"issue":"1","key":"975_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000346606","volume":"41","author":"BF Verhaaren","year":"2013","unstructured":"Verhaaren BF, Vernooij MW, Dehghan A, Vrooman HA, de Boer R, Hofman A, Witteman JC, Niessen WJ, Breteler MM, van der Lugt A, et al. The relation of uric acid to brain atrophy and cognition: the Rotterdam scan study. Neuroepidemiology. 2013;41(1):29\u201334.","journal-title":"Neuroepidemiology"},{"issue":"4","key":"975_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3233\/JAD-160028","volume":"52","author":"MA Beydoun","year":"2016","unstructured":"Beydoun MA, Canas JA, Dore GA, Beydoun HA, Rostant OS, Fanelli-Kuczmarski MT, Evans MK, Zonderman AB. Serum uric acid and its association with longitudinal cognitive change among urban adults. J Alzheimers Dis. 2016;52(4):1415\u201330.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"975_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000210040","volume":"27","author":"C Ruggiero","year":"2009","unstructured":"Ruggiero C, Cherubini A, Lauretani F, Bandinelli S, Maggio M, Di Iorio A, Zuliani G, Dragonas C, Senin U, Ferrucci L. Uric acid and dementia in community-dwelling older persons. Dement Geriatr Cogn Disord. 2009;27(4):382\u20139.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Pt 2","key":"975_CR22","first-page":"377","volume":"132","author":"SM Euser","year":"2009","unstructured":"Euser SM, Hofman A, Westendorp RG, Breteler MM. Serum uric acid and cognitive function and dementia. Brain. 2009;132(Pt 2):377\u201382.","journal-title":"Brain"},{"key":"975_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-015-0642-1","volume":"17","author":"JY Hong","year":"2015","unstructured":"Hong JY, Lan TY, Tang GJ, Tang CH, Chen TJ, Lin HY. Gout and the risk of dementia: a nationwide population-based cohort study. Arthritis Res Ther. 2015;17:139.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"975_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/annrheumdis-2016-210767","volume":"77","author":"Augustin Latourte","year":"2017","unstructured":"Latourte A, Soumare A, Bardin T, Perez-Ruiz F, Debette S, Richette P. Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study. Ann Rheum Dis. 2018;77:328\u201335.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"975_CR25","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum. 2007;57(5):822\u20139.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"975_CR26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","volume":"46","author":"PS Romano","year":"1993","unstructured":"Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075\u20139 discussion 1081-1090.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"975_CR27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","volume":"43","author":"H Quan","year":"2008","unstructured":"Quan H, Li B, Saunders LD, Parsons GA, Nilsson CI, Alibhai A, Ghali WA, Investigators I. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43(4):1424\u201341.","journal-title":"Health Serv Res"},{"key":"975_CR28","unstructured":"U.S. Census Bureau. National Population Projections. I. Summary files. Total population by age, sex, race and Hispanic origin. (NP-T4-F). Projections of the total resident population by 5-year age groups, race and Hispanic origin with special age categories: middle series. 2025 to 2045. Available at: https:\/\/www2.census.gov\/programs-surveys\/popproj\/tables\/2000\/2000-national-summary-tables\/np-t4-f.pdf . Accessed 10 Nov 2018."},{"issue":"1","key":"975_CR29","first-page":"4","volume":"46","author":"JE Banta","year":"2017","unstructured":"Banta JE. Dementia: morbidity and medications. Age Ageing. 2017;46(1):4\u20135.","journal-title":"Age Ageing"},{"issue":"2","key":"975_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/153331750201700210","volume":"17","author":"M Sanderson","year":"2002","unstructured":"Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK. Co-morbidity associated with dementia. Am J Alzheimers Dis Other Demen. 2002;17(2):73\u20138.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"3","key":"975_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00002093-199907000-00011","volume":"13","author":"E Witthaus","year":"1999","unstructured":"Witthaus E, Ott A, Barendregt JJ, Breteler M, Bonneux L. Burden of mortality and morbidity from dementia. Alzheimer Dis Assoc Disord. 1999;13(3):176\u201381.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7113","key":"975_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787\u201395.","journal-title":"Nature"},{"issue":"12","key":"975_CR33","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","volume":"21","author":"D Pratico","year":"2001","unstructured":"Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci. 2001;21(12):4183\u20137.","journal-title":"J Neurosci"},{"issue":"Pt 1","key":"975_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/bj3400143","volume":"340","author":"M Bagnati","year":"1999","unstructured":"Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J. 1999;340(Pt 1):143\u201352.","journal-title":"Biochem J"},{"issue":"1","key":"975_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.semnephrol.2004.09.007","volume":"25","author":"J Kanellis","year":"2005","unstructured":"Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25(1):39\u201342.","journal-title":"Semin Nephrol"},{"issue":"2","key":"975_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/abbi.2000.1721","volume":"376","author":"GL Squadrito","year":"2000","unstructured":"Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys. 2000;376(2):333\u20137.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"975_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1","volume":"53","author":"ZF Yu","year":"1998","unstructured":"Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res. 1998;53(5):613\u201325.","journal-title":"J Neurosci Res"},{"issue":"1","key":"975_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0021-9150(99)00214-2","volume":"148","author":"FJ Nieto","year":"2000","unstructured":"Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 2000;148(1):131\u20139.","journal-title":"Atherosclerosis"},{"issue":"17","key":"975_CR39","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321.","journal-title":"N Engl J Med"},{"issue":"8","key":"975_CR40","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/annrheumdis-2015-208161","volume":"75","author":"SC Kim","year":"2016","unstructured":"Kim SC, Liu J, Solomon DH. Risk of incident atrial fibrillation in gout: a cohort study. Ann Rheum Dis. 2016;75(8):1473\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"975_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.24612","volume":"61","author":"SY Kim","year":"2009","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(7):885\u201392.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"975_CR42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62(2):170\u201380.","journal-title":"Arthritis Care Res"},{"issue":"5134","key":"975_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262(5134):689\u201395.","journal-title":"Science"},{"issue":"3","key":"975_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3(3):205\u201314.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"975_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med. 1999;131(1):7\u201313.","journal-title":"Ann Intern Med"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-0975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12877-018-0975-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-0975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T10:55:48Z","timestamp":1720781748000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-018-0975-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1186\/s12877-018-0975-0","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Alabama at Birmingham\u2019s Institutional Review Board approved this study and waived the need for informed consent for this database study. All investigations were conducted in conformity with ethical principles of research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JAS has received consultant fees from Crealta\/Horizon, Fidia, UBM LLC, Medscape, WebMD, the National Institutes of Health and the American College of Rheumatology. JAS owns stock options in Amarin pharmaceuticals, Inc. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS served as a member of the American College of Rheumatology\u2019s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees, the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and the co-chair of the ACR Criteria and Response Criteria subcommittee. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. DC has no conflicts to declare. There are no non-financial competing interests for any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"281"}}